- New Hampshire lawmakers advanced HB 1809 to legalize the regulated use of natural psilocybin for medical purposes, such as treatment-resistant depression and PTSD, while rejecting HB 1796 due to fiscal concerns.
- Separately, the House approved bills to legalize marijuana and to put the issue before voters in November, despite clear opposition from the governor.
- A bill allowing medical marijuana dispensaries to convert to for-profit entities was also approved by the House.

New Hampshire Approves Bipartisan Medical Psilocybin Bill

Jan 30, 2026

Source:

Kyle Jaeger

Marijuana Moment

New Hampshire is taking a major step toward expanding natural medicine options. State lawmakers recently advanced a bipartisan bill, HB 1809, which aims to legalize medical psilocybin for patients struggling with treatment-resistant depression, PTSD, and substance use disorders. While a more complex psychedelics measure was rejected due to budget concerns, this approved path would allow licensed professionals to provide natural psilocybin in a highly supervised, three-session therapeutic setting.

In a massive win for the broader plant-medicine community, the House also moved forward with several cannabis reforms. These include bills to legalize adult-use marijuana, a proposal to let voters decide the issue at the ballot this November, and a measure allowing medical dispensaries to operate as for-profit businesses.

For the average enthusiast, this is a huge signal that the "Live Free or Die" state is finally listening to the community. Even with a potential gubernatorial veto looming, the momentum for both cannabis and psilocybin shows that accessible, natural alternatives are becoming a mainstream priority, potentially ending years of unnecessary prohibition.